epsotech focuses on core business

Press release, Jülich, December 2021

epsotech Holding GmbH has sold its French subsidiary Carolex to the US group Pacur (Oshkosh, Wisconsin/USA; www.pacur.com) at the end of November 2021.

Pacur is a manufacturer of packaging solutions for medical technology and has belonged to the private equity investment company Gryphon Investors (San Francisco / USA; www.gryphoninvestors.com) since last year. Carolex is the first acquisition of Pacur, which intends to expand in Europe.

The epsotech Group will fully focus on the further development of its recycling strategy within its core business - the production of high-quality plastic sheets and foils. The establishment of sustainable and innovative products is the main focus here. The product range of Carolex, namely flexible PETG foils or plastic packaging, was therefore not part of the core business.

epsotech will generate sales of approximately EUR 160 million in 2021 with approximately 500 employees (excluding Carolex). The group includes 7 production sites in 6 European countries, representing a total production capacity of approx. 100,000 tons/year.

Carina Marotta
epsotech Marketing